Regulatory Frameworks

The first step in developing a Combined & Companion QMS is to understand the regulatory frameworks governing medical devices and combination products. In the US, the FDA regulates these products under the Federal Food, Drug, and Cosmetic Act and associated regulations, including 21 CFR Part 820 (Quality System Regulation). In the EU, the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) outline the requirements for compliance.

Objectives: The objective of this step is to familiarize the quality management team with applicable regulations and standards, including ISO 13485 for medical devices and ISO 14971 for risk management.

Documentation: Key documents include regulatory guidelines, internal compliance checklists, and training materials that outline regulatory requirements.

Roles: Quality managers, regulatory affairs professionals, and compliance officers should collaborate to ensure a comprehensive understanding of the regulatory landscape.

Inspection Expectations: During inspections, regulatory bodies will assess the organization’s understanding of applicable regulations and its ability to implement them effectively.

Step 2: Defining the Scope of the QMS

Once the regulatory framework is understood, the next step is to define the scope of the QMS. This involves identifying the products and processes that will be covered under the QMS, including manufacturing, design, and post-market surveillance.

Objectives: The objective is to establish clear boundaries for the QMS, ensuring that all relevant activities are included while excluding those that do not impact product quality or compliance.

Documentation: A scope document should be created, detailing the products, processes, and locations included in the QMS. This document should also reference relevant regulatory requirements.

Roles: Quality managers should lead this effort, with input from cross-functional teams, including production, engineering, and regulatory affairs.

Inspection Expectations: Inspectors will review the scope document to ensure it accurately reflects the organization’s operations and compliance obligations.

Step 3: Developing QMS Policies and Procedures

The development of QMS policies and procedures is a critical phase in establishing a Combined & Companion QMS. These documents outline the processes and responsibilities necessary to achieve compliance and ensure product quality.

Objectives: The goal is to create comprehensive policies and procedures that align with regulatory requirements and industry best practices.

Documentation: Key documents include the Quality Manual, Standard Operating Procedures (SOPs), and work instructions. These should cover areas such as document control, change management, and nonconformance handling.

Roles: Quality managers should oversee the development of these documents, with contributions from subject matter experts in relevant areas.

Inspection Expectations: Inspectors will evaluate the adequacy and implementation of QMS policies and procedures during audits.

Step 4: Implementing Training Programs

Effective training programs are essential for ensuring that all employees understand their roles within the QMS and are equipped to comply with regulatory requirements. Training should be tailored to the specific needs of different roles within the organization.

Objectives: The objective is to ensure that all personnel are knowledgeable about the QMS and their specific responsibilities related to quality management.

Documentation: Training records, including attendance logs and training materials, should be maintained to demonstrate compliance.

Roles: Quality managers should coordinate training efforts, while department heads are responsible for ensuring their teams receive the necessary training.

Inspection Expectations: Inspectors will review training records to verify that employees have received appropriate training and understand their responsibilities.

Step 5: Establishing a Risk Management Process

Risk management is a fundamental component of a Combined & Companion QMS. Organizations must identify, assess, and mitigate risks associated with their products and processes to ensure compliance and product safety.

Objectives: The goal is to implement a systematic approach to risk management that complies with ISO 14971 and other relevant standards.

Documentation: Risk management plans, risk assessments, and risk mitigation strategies should be documented and regularly updated.

Roles: Quality managers, product development teams, and regulatory affairs professionals should collaborate to develop and implement the risk management process.

Inspection Expectations: Inspectors will evaluate the effectiveness of the risk management process and its integration into the overall QMS.

Step 6: Conducting Internal Audits

Internal audits are a vital tool for assessing the effectiveness of the QMS and ensuring ongoing compliance with regulatory requirements. These audits should be conducted regularly to identify areas for improvement.

Objectives: The objective is to evaluate the QMS against established policies and procedures, regulatory requirements, and industry standards.

Documentation: Audit plans, checklists, and reports should be created and maintained to document the audit process and findings.

Roles: Quality managers should lead the internal audit program, while trained auditors from various departments should conduct the audits.

Inspection Expectations: Inspectors will review internal audit reports to assess the effectiveness of the audit process and the organization’s response to identified nonconformities.

Step 7: Managing Nonconformities and Corrective Actions

Effective management of nonconformities and corrective actions is essential for maintaining compliance and improving the QMS. Organizations must have processes in place to identify, investigate, and resolve nonconformities.

Objectives: The goal is to implement a systematic approach to managing nonconformities that aligns with ISO 9001 and ISO 13485 requirements.

Documentation: Nonconformance reports, corrective action plans, and follow-up documentation should be maintained to track the resolution of issues.

Roles: Quality managers should oversee the nonconformance management process, while department heads are responsible for addressing issues within their areas.

Inspection Expectations: Inspectors will evaluate the organization’s ability to manage nonconformities and the effectiveness of corrective actions taken.

Step 8: Continuous Improvement

Continuous improvement is a core principle of a Combined & Companion QMS. Organizations should foster a culture of quality and encourage ongoing evaluation and enhancement of processes and products.

Objectives: The objective is to establish mechanisms for identifying opportunities for improvement and implementing changes that enhance product quality and compliance.

Documentation: Continuous improvement initiatives, including process improvement plans and performance metrics, should be documented and reviewed regularly.

Roles: Quality managers should lead continuous improvement efforts, while all employees should be encouraged to contribute ideas and feedback.

Inspection Expectations: Inspectors will assess the organization’s commitment to continuous improvement and the effectiveness of implemented initiatives.

Conclusion

Establishing a Combined & Companion QMS for medical devices and combination products in contract manufacturing and outsourced operations is a complex but essential undertaking. By following the outlined steps, organizations can ensure compliance with regulatory requirements and enhance product quality. Continuous engagement with regulatory bodies, such as the FDA, and adherence to standards like ISO 13485 will further strengthen the QMS and support successful operations in the regulated industry.